
The ONWARDS 2 trial achieved its primary endpoint of demonstrating non-inferiority in reducing HbA1c at week 26 with insulin icodec vs insulin degludec.

The ONWARDS 2 trial achieved its primary endpoint of demonstrating non-inferiority in reducing HbA1c at week 26 with insulin icodec vs insulin degludec.

The observational study found that longer duration of disease conferred a 32% greater risk of obesity and that nonatopic asthma carried at 47% greater risk.
When talking to younger cannabis users, Henry Mahncke, PhD, says it is important to first understand the underlying causes of use before counseling against it.

The US FDA expanded approval of remdesivir this week to include pediatric patients aged 28 days and older, the first COVID-19 treatment indicated for this population.

Tirzepatide was associated with reductions in body weight of up to 22.5% over 72 weeks in the global phase 3 registration trial.

The biotechnology company said on Thursday that similar requests are underway with international regulatory authorities.

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
_ccexpress.jpeg?w=350&fit=crop&auto=format)
Study addresses the concern that state opioid prescription laws may lead to some chronic pain patients missing out on critical pain treatment.

As many as 40 000 pharmacies will soon have supplies of Paxlovid while the administration ramps up communications to clinicians and patients on access and use.
USPSTF states low-dose aspirin should be considered for CVD prevention on a case-by-case basis in adults aged 40-59 yrs with a 10% or greater 10-year CVD risk.

More than one-third of survey respondents began drinking before age 15; the heaviest drinkers had double the risk for cirrhosis, CVD, pancreatitis, and neuropathy.

A skateboarding accident brings a man in his 30s to the ED complaining of wrist pain. Can you make the diagnosis based on the x-ray?

Asthma-COPD overlap and obesity mutually exacerbate each other and an early program of pulmonary rehabilitation shows promise to help both.
Dylan Steen, MD talks about several SuperWIN results that caught him happily by surprise and suggest plenty of room for follow-up research.

Infectious disease expert and clinical investigator Rodger MacArthur, MD, considers what we know now that we didn't on March 12, 2020.

A nondescript, postage-paid envelope accompanying an opioid prescription, and patient education on discarding unused tablets are proposed.

SAMPLE: Between 2019 and 2020, the rate of reported gonorrhea increased 10%. True or false? Plus, 6 more questions based on the CDC’s 2020 STD Surveillance Report.
Yale headache specialist Christopher Gottschalk, MD, talks about the opportunities to make a marked difference in the quality of patients' lives.

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

NAFLD is a key risk factor for ASCVD and widely underdiagnosed. This Guideline Topline summarizes new AHA warnings, guidance.